Holdings (Monthly)
Guide ↗
The Hartford Healthcare Fund
· Hartford Mutual Funds, Inc| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 532457108 | Apr 2024 | 105,506 | $109.4M | 13.12% | EC |
| 2 | Merck & Co Inc | 58933Y105 | Apr 2024 | 434,365 | $47.9M | 5.74% | EC |
| 3 | Johnson & Johnson | 478160104 | Jan 2026 | 186,167 | $42.3M | 5.07% | EC |
| 4 | UnitedHealth Group Inc | 91324P102 | Apr 2024 | 134,871 | $38.7M | 4.64% | EC |
| 5 | AbbVie Inc | 00287Y109 | Apr 2024 | 143,697 | $32.0M | 3.84% | EC |
| 6 | Intuitive Surgical Inc | 46120E602 | Apr 2024 | 58,069 | $29.3M | 3.51% | EC |
| 7 | Danaher Corp | 235851102 | Apr 2024 | 116,573 | $25.5M | 3.06% | EC |
| 8 | Abbott Laboratories | 002824100 | Apr 2024 | 225,393 | $24.6M | 2.95% | EC |
| 9 | Edwards Lifesciences Corp | 28176E108 | Apr 2024 | 290,008 | $23.6M | 2.83% | EC |
| 10 | Cencora Inc | 03073E105 | Apr 2024 | 63,164 | $22.7M | 2.72% | EC |
| 11 | Medtronic PLC | 000000000 | Apr 2024 | 219,940 | $22.6M | 2.71% | EC |
| 12 | Vertex Pharmaceuticals Inc | 92532F100 | Apr 2024 | 43,668 | $20.5M | 2.46% | EC |
| 13 | Thermo Fisher Scientific Inc | 883556102 | Apr 2024 | 27,039 | $15.6M | 1.88% | EC |
| 14 | Elevance Health Inc | 036752103 | Jan 2026 | 42,513 | $14.7M | 1.76% | EC |
| 15 | HCA Healthcare Inc | 40412C101 | Apr 2024 | 27,119 | $13.2M | 1.59% | EC |
| 16 | CVS Health Corp | 126650100 | Jan 2026 | 172,712 | $12.9M | 1.54% | EC |
| 17 | UCB SA | 000000000 | Apr 2024 | 41,357 | $12.6M | 1.51% | EC |
| 18 | Cardinal Health Inc | 14149Y108 | Jan 2026 | 56,537 | $12.1M | 1.46% | EC |
| 19 | Boston Scientific Corp | 101137107 | Apr 2024 | 129,458 | $12.1M | 1.45% | EC |
| 20 | GSK PLC | 000000000 | Apr 2024 | 424,449 | $11.0M | 1.32% | EC |
| 21 | Agilent Technologies Inc | 00846U101 | Apr 2024 | 78,501 | $10.5M | 1.26% | EC |
| 22 | Stryker Corp | 863667101 | Apr 2024 | 26,694 | $9.9M | 1.18% | EC |
| 23 | United Therapeutics Corp | 91307C102 | Apr 2024 | 19,171 | $9.0M | 1.08% | EC |
| 24 | Argenx SE | 04016X101 | Apr 2024 | 10,637 | $8.9M | 1.07% | EC |
| 25 | Dexcom Inc | 252131107 | Apr 2024 | 114,063 | $8.3M | 1.00% | EC |
| 26 | Biogen Inc | 09062X103 | Apr 2024 | 44,436 | $8.0M | 0.96% | EC |
| 27 | STERIS PLC | 000000000 | Apr 2024 | 29,627 | $7.8M | 0.93% | EC |
| 28 | AstraZeneca PLC | 046353108 | Apr 2024 | 81,513 | $7.6M | 0.91% | EC |
| 29 | Ionis Pharmaceuticals Inc | 462222100 | Jan 2026 | 82,046 | $6.8M | 0.81% | EC |
| 30 | Regeneron Pharmaceuticals Inc | 75886F107 | Apr 2024 | 8,493 | $6.3M | 0.75% | EC |
| 31 | Galderma Group AG | 000000000 | Apr 2024 | 33,699 | $6.3M | 0.75% | EC |
| 32 | Bristol-Myers Squibb Co | 110122108 | Jan 2026 | 109,938 | $6.1M | 0.73% | EC |
| 33 | Bio-Techne Corp | 09073M104 | Apr 2024 | 92,531 | $5.9M | 0.71% | EC |
| 34 | Ascendis Pharma A/S | 04351P101 | Apr 2024 | 25,754 | $5.8M | 0.70% | EC |
| 35 | Elanco Animal Health Inc | 28414H103 | Apr 2024 | 234,258 | $5.6M | 0.68% | EC |
| 36 | Revolution Medicines Inc | 76155X100 | Apr 2024 | 57,054 | $5.5M | 0.66% | EC |
| 37 | Avantor Inc | 05352A100 | Jan 2026 | 492,326 | $5.4M | 0.64% | EC |
| 38 | Oculis Holding AG | 000000000 | Apr 2024 | 187,112 | $5.3M | 0.64% | EC |
| 39 | Structure Therapeutics Inc | 86366E106 | Apr 2024 | 59,751 | $5.3M | 0.63% | EC |
| 40 | Alignment Healthcare Inc | 01625V104 | Jan 2026 | 233,573 | $5.3M | 0.63% | EC |
| 41 | Option Care Health Inc | 68404L201 | Apr 2024 | 153,121 | $5.2M | 0.62% | EC |
| 42 | Incyte Corp | 45337C102 | Jan 2026 | 51,898 | $5.2M | 0.62% | EC |
| 43 | ICON PLC | 000000000 | Apr 2024 | 28,338 | $5.1M | 0.61% | EC |
| 44 | Alnylam Pharmaceuticals Inc | 02043Q107 | Apr 2024 | 14,479 | $4.9M | 0.59% | EC |
| 45 | Kymera Therapeutics Inc | 501575104 | Jan 2026 | 67,033 | $4.9M | 0.58% | EC |
| 46 | Encompass Health Corp | 29261A100 | Apr 2024 | 51,367 | $4.9M | 0.58% | EC |
| 47 | QIAGEN NV | 000000000 | Apr 2024 | 87,533 | $4.7M | 0.56% | EC |
| 48 | Cytokinetics Inc | 23282W605 | Apr 2024 | 73,424 | $4.6M | 0.56% | EC |
| 49 | Madrigal Pharmaceuticals Inc | 558868105 | Jan 2026 | 9,331 | $4.6M | 0.55% | EC |
| 50 | Arcus Biosciences Inc | 03969F109 | Jan 2026 | 216,338 | $4.6M | 0.55% | EC |
| 51 | Mirum Pharmaceuticals Inc | 604749101 | Jan 2026 | 43,558 | $4.5M | 0.54% | EC |
| 52 | Celldex Therapeutics Inc | 15117B202 | Apr 2024 | 173,588 | $4.3M | 0.51% | EC |
| 53 | Disc Medicine Inc | 254604101 | Jan 2026 | 54,869 | $4.2M | 0.51% | EC |
| 54 | Pharvaris NV | 000000000 | Apr 2024 | 155,094 | $4.2M | 0.50% | EC |
| 55 | PTC Therapeutics Inc | 69366J200 | Apr 2024 | 54,649 | $4.1M | 0.49% | EC |
| 56 | Natera Inc | 632307104 | Jan 2026 | 17,791 | $4.1M | 0.49% | EC |
| 57 | Viridian Therapeutics Inc | 92790C104 | Jan 2026 | 124,120 | $4.1M | 0.49% | EC |
| 58 | Dianthus Therapeutics Inc | 252828108 | Jan 2026 | 72,022 | $3.8M | 0.46% | EC |
| 59 | Vaxcyte Inc | 92243G108 | Apr 2024 | 70,596 | $3.8M | 0.45% | EC |
| 60 | Protagonist Therapeutics Inc | 74366E102 | Jan 2026 | 45,764 | $3.7M | 0.45% | EC |
| 61 | Xenon Pharmaceuticals Inc | 98420N105 | Apr 2024 | 90,277 | $3.7M | 0.44% | EC |
| 62 | Apellis Pharmaceuticals Inc | 03753U106 | Apr 2024 | 151,877 | $3.4M | 0.41% | EC |
| 63 | Soleno Therapeutics Inc | 834203309 | Apr 2024 | 85,170 | $3.3M | 0.39% | EC |
| 64 | Apogee Therapeutics Inc | 03770N101 | Jan 2026 | 50,042 | $3.3M | 0.39% | EC |
| 65 | Inspire Medical Systems Inc | 457730109 | Apr 2024 | 41,087 | $3.1M | 0.37% | EC |
| 66 | Nuvalent Inc | 670703107 | Apr 2024 | 29,773 | $3.1M | 0.37% | EC |
| 67 | Crinetics Pharmaceuticals Inc | 22663K107 | Apr 2024 | 59,607 | $3.0M | 0.36% | EC |
| 68 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 000000000 | Apr 2024 | 330,781 | $2.9M | 0.35% | EC |
| 69 | Immunocore Holdings PLC | 45258D105 | Apr 2024 | 88,743 | $2.9M | 0.35% | EC |
| 70 | Acadia Healthcare Co Inc | 00404A109 | Apr 2024 | 207,010 | $2.8M | 0.33% | EC |
| 71 | HeartFlow Inc | 42238D107 | Jan 2026 | 90,813 | $2.7M | 0.33% | EC |
| 72 | GenFleet Therapeutics Shanghai Inc | 000000000 | Apr 2024 | 669,000 | $2.6M | 0.32% | EC |
| 73 | Scholar Rock Holding Corp | 80706P103 | Jan 2026 | 58,010 | $2.6M | 0.31% | EC |
| 74 | Immunome Inc | 45257U108 | Jan 2026 | 104,408 | $2.6M | 0.31% | EC |
| 75 | Newamsterdam Pharma Co NV | 000000000 | Apr 2024 | 68,032 | $2.1M | 0.25% | EC |
| 76 | Mineralys Therapeutics Inc | 603170101 | Jan 2026 | 64,769 | $2.0M | 0.24% | EC |
| 77 | Adaptive Biotechnologies Corp | 00650F109 | Jan 2026 | 106,631 | $2.0M | 0.24% | EC |
| 78 | Trevi Therapeutics Inc | 89532M101 | Jan 2026 | 167,824 | $1.8M | 0.21% | EC |
| 79 | Aktis Oncology Inc | 01021M104 | Jan 2026 | 81,156 | $1.6M | 0.20% | EC |
| 80 | Fixed Income Clearing Corp | 000000000 | Apr 2024 | 1,558,962 | $1.6M | 0.19% | RA |
| 81 | State Street Global Advisors | 857509301 | Jan 2026 | 1,142,048 | $1.1M | 0.14% | STIV |
| 82 | CG oncology Inc | 156944100 | Jan 2026 | 21,540 | $1.1M | 0.13% | EC |
| 83 | Corvus Pharmaceuticals Inc | 221015100 | Jan 2026 | 29,300 | $607K | 0.07% | EC |
| 84 | CONTRA ABIOMED INC | 003CVR016 | Apr 2024 | 7,416 | $8K | 0.00% | DE |